- [21]Zhou Y*（通讯作者）, Yoshida S, Li Y, Zhang L, Zou J, Zhao H, Peng Y, Wang JH, Zeng H, Fu X#, Zhang L#.Microarray Analysis of Long Non-Coding RNAs and Messenger RNAs in a Mouse Model of Oxygen-Induced Retinopathy[J].Int J Med Sci, 2019, 16 (4) : 537-547.
- [22]Zhou Y*(通讯作者), Li Y.Interleukin-17: The Role for Pathological Angiogenesis in Ocular Neovascular Diseases[J].Tohoku J Exp Med, 2019
- [23]Zhou Y*(通讯作者), Jia S, Shi J, Nakama T, Kobayashi Y, Zou J, Zeng H, Zhang L, Yoshida S, Cao M#, Peng Y#.Attenuation of periostin in retinal Müller glia by TNF-α and IFN-γ[J].Int J Ophthalmol, 2019
- [24]Tang LS, Zhang LS, Kobayashi Y, Peng YQ, Yoshida S*, Zhou YD*.Diverse roles of macrophages in intraocular neovascular diseases: a review[J].Int J Ophthalmol, 2017
- [25]et al, Kobayashi Y, Yoshimura T, Kubo Y, Yoshida S*, Zhou Y.Different distributions of M1 and M2 macrophages in a mouse model of laser-induced choroidal neovascularization[J].Mol Med Rep, 2017
- [26]et al., Nakama T, Kobayashi Y, Y, Kubo, Yoshida S*, Zhou Y.Interleukin-12 inhibits pathological neovascularization in mouse model of oxygen-induced retinopathy[J].Sci Rep, 2016
- [27]et al., Kobayashi Y, Yoshimura T, Nakao S, Yoshida S*, Zhou Y.M2 macrophages enhance pathological neovascularization in the mouse model of oxygen-induced retinopathy[J].Invest Ophthalmol Vis Sci, 2015
- [28]Zhou Y* (通讯作者), Tang L, Peng Y.Subretinal Injection: A Review on the Novel Route of Therapeutic Delivery for Vitreoretinal Diseases[J].Ophthalmic Res, 2017
- [29]Zhou Y* (通讯作者), He Y, Hu Y, Hu W, Zhao Y#, Peng Y#.Reduction of retinal nerve fiber layer thickness in vigabatrin-exposed patients: A meta-analysis[J].Clin Neurol Neurosurg, 2017
- [30]Zhou YD* (通讯作者), Yoshida S, Tang LS, Peng YQ.Applications of CRISPR/Cas9 in Retinal Degenerative Diseases[J].Int J Ophthalmol, 2017
- [31]Shi J*, Jia S*, Zeng H, Zhou Y, Liang Y, Zhang L.A Missense Mutation in GJA8 Encoding Connexin 50 in a Chinese Pedigree with Autosomal Dominant Congenital Cataract[J].Tohoku J Exp Med, 2018
- [32]et al, Ishikawa K, Zhou Y, Kobayashi Y, Yoshida S*, Wada I.Quantifying metamorphopsia with M-CHARTS in patients with idiopathic macular hole[J].Clin Ophthalmol, 2017
- [33]et al., Zhou Y, Kobayashi Y, Kubo Y, Ishikawa K, Yoshida S*, Nakama T.Therapeutic Effect of Novel Single-Stranded RNAi Agent Targeting Periostin in Eyes with Retinal Neovascularization[J].Mol Ther Nucleic Acids, 2017
- [34]et al., Hu X, Iao TWU, Lee JH, Wang R, Wang JH.Public Attitudes toward Gene Therapy in China[J].Mol Ther Methods Clin Dev, 2017
- [35]et al., Ishikawa K, Nakama T, Zhou Y, Yoshida S*, Kobayashi Y.Tenascin-C promotes angiogenesis in fibrovascular membranes in eyes with proliferative diabetic retinopathy[J].Mol Vis, 2016
- [36]et al., Ishikawa K, Nakama T, Zhou Y, Yoshida S, Kobayashi Y.Tenascin-C secreted by transdifferentiated retinal pigment epithelial cells promotes choroidal neovascularization via integrin αV[J].Lab Invest, 2016
- [37]et al., Zhou Y, Arima M, Kaizu Y, Arita R, Nakao S*, Yamaguchi M.Vascular Normalization by ROCK Inhibitor: Therapeutic Potential of Ripasudil (K-115) Eye Drop in Retinal Angiogenesis and Hypoxia[J].Invest Ophthalmol Vis Sci, 2016
- [38]et al., Nakama T, Zhou Y, Kobayashi Y, Yoshida S*, Ishikawa K.Microarray analysis of gene expression in fibrovascular membranes excised from patients with proliferative diabetic retinopathy[J].Invest Ophthalmol Vis Sci, 2015
- [39]et al., Nakama T, Zhou Y, Kobayashi Y, Kubo Y, Yoshida S*.Increased vitreous concentrations of MCP-1 and IL-6 after vitrectomy in patients with proliferative diabetic retinopathy: possible association with postoperative macular edema[J].Br J Ophthalmol, 2015
- [40]et al., Ishikawa K, Zhou Y, Nakama T, Kobayashi Y, Yoshida S.Increased expression of M-CSF and IL-13 in vitreous of patients with proliferative diabetic retinopathy: Implications for M2 macrophage-involving fibrovascular membrane formation[J].Br J Ophthalmol, 2015